Endologix hits primary endpoints in one-year follow-up data for DETOUR2 trial

Retrieved on: 2024-05-13 16:19:54

Tags for this article:

Interventional radiology

Interventional cardiology

Medical devices

Stent

Femoral artery

Peripheral artery disease

Click the tags to see associated articles and topics

Endologix hits primary endpoints in one-year follow-up data for DETOUR2 trial. View article details on hiswai:

Excerpt

Field Medical begins ventricular PFA technology trial. Endologix also reported low rates of deep venous thrombosis (DVT) and clinically driven target ...

Article found on: www.medicaldevice-network.com

View Original Article